Print

Biolex, Inc. Pulls Planned IPO Due to Market Conditions  
2/4/2008 7:03:41 AM

WASHINGTON, Feb 1 (Reuters) - Clinical-stage biopharmaceutical company Biolex Inc on Friday canceled a planned initial public offering, citing market conditions.
//-->